Status:
COMPLETED
Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Ascites
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is look at how treatments for ascites affect quality of life. Your quality of life is the ability for you to enjoy the normal things you do. Ascites (pronounced as-ī-tees) is...
Eligibility Criteria
Inclusion
- Patients diagnosed with a stage IV malignancy or end-stage disease documented in patient's chart.
- Patients referred to interventional radiology for treatment of refractory ascites with the placement of a permanent catheter including, but not limited to, a Tenckhoff catheter, a PleurX catheter, or a Denver Shunt.
- Fluency in English to enable instrument and interview completion.
- Patients must be at least 18 years of age.
- Patients must be physically capable of completing instruments and/or interview.
- Patients must be able to comprehend and execute informed consent.
Exclusion
- Unable to complete questionnaire due to a significant physical or mental deficits as assessed by the consenting professional.
- Proxy completion is not accepted
- Medical or psychiatric condition that, in the judgment of the investigator, prevents appropriate comprehension and execution of either the informed consent or the study instrument
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01188746
Start Date
August 1 2010
End Date
February 1 2020
Last Update
February 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065